The UK government is shortly to seek nominations for members of a newtask force whose remit will be to find ways to improve advice and support for patients on understanding their medicines and how to take them. Currently, "up to half of all people with chronic disease end up using their medicines in a way that is not fully effective, and the consequences can be serious," said Health Minister Lord Philip Hunt.
L1.3 million ($1.8 million) will be made available over the next two years to support the work of the task force, which will bring together patients, the National Health Service, social care, health care professions and the pharmaceutical industry, Lord Hunt noted. The task force will implement a national strategy to integrate partnership in medicines, taking ito account the way the NHS works at all levels, he said. It will develop ways to improve advice and support for patients on their medicines and how to take them, and improve their understanding of their medicines' action and use, of side effects and how to manage them, as well as of the treatment options that are available to them.
Lord Hunt has also announced that three of the seven pilot proposals announced in December 2000 to test the benefits, costs and risks of transmitting prescriptions electronically have now been approved. The three pilot schemes will be run by the following consortia:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze